Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | REGN5093-M114 |
Trade Name | |
Synonyms | REGN5093 M114|REGN5093M114 |
Drug Descriptions |
REGN5093-M114 is an antibody-drug conjugate (ADC) comprised of a biparatopic MET antibody linked to a maytansinoid payload, which potentially inhibits tumor growth (Cancer Res 2022;82(12_Suppl):Abstract nr LB515A). |
DrugClasses | MET Antibody 31 |
CAS Registry Number | NA |
NCIT ID | C182004 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
REGN5093-M114 | REGN5093-M114 | 0 | 1 |